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LETTERS TO THE EDITOR 
We are pleased to receive Letters to the Editor on appropria te subjects. These le tters should be submitted 
in typewritten form , double-spaced, a nd are not to exceed 2'12 pages. When appropriate, we will solicit com-
ments from the original authors. All Letters to the Editor are subject to editing and possible abridgment. 
REGIONAL VARIATION OF IMMUNOGLOBULIN DEPOSITS 
IN NZB/ W FI MICE: A TAIL-END SUGGESTION. 
" ... we do fear this body hath a tail/ more perilous than the head." 
W. S hakespeare 
(in Cymbeline iv-2-144) 
T o the Editor: 
We found the article by Drs. Sontheimer and Gilliam (J Invest 
Dermalot 72:25-28, 1979) on the regional variation of subepidermal 
immunoglobulin (subepi-Ig) deposits in the NZB/ W FI mouse well 
done and interesting. Of special note was their finding that subepi-Ig 
was present on the keratinizing, hair-bearing surface of mouse lip, and 
its complete absence under the mucosal surface. They hypothesize that 
at the mucosal surface, the DNA antigen becomes " unavailable to react 
with DNA antibodies at the D-E junction" s ince the epithelia l ce lls 
t hat. are shed at the mucosal surface stili contain their nuclei and take 
the DNA with them [1). 
Epidermal cytoplasmic antibodies (ECA) have been linked to kera-
tinization an.d presumably can detect distinctly different cytoplasmic 
molecules in keratinocytes "programmed" for mucous, parakeratotic or 
orthokeratotic differentiation. Therefore, the target antigens for ECA 
seem to be molecules involved in keratinocyte differentiation (2). Mol-
ecules may change their antigenic characteristics depending upon the 
type and stage of keratinization in the cell. Further, t here is some 
evidence to suggest that in certain situations, intracellular molecules 
(antigens), other than DNA, may be deposited into the basement 
membrane zone at the D-E junction (3). Cytoplasmic proteins and 
antibodies to these cytoplasmic proteins have also been described in 
systemic lupus erythematosis [4]. 
S ince ther NZB/W FI mice were already injected with tritium-
la beled thymidine and biopsies taken from the lip, back and abdomen, 
it would have been interesting if they had obtained, as well, a biopsy 
from the tail for their direct immunofluorescent studies; for in that 
location there are a lternating bands of parakeratotic and orthokeratotic 
epidermis [5]. It would have been additionally interesting if they had 
tested the sloughed epidermal cells from the parakeratotic ta il region 
with ethidium bromide marker for the presence of DNA along with 
measuring the basal cell labeling indexes of these tail bands that have 
the same blood supply, same cephalic-caudal position and the same 
tissue consistency. 
Assuming that DNA antigen is sloughed from the parakeratotic ta il 
region and is therefore unavailable at the D-E junction, these additional 
procedures would have confirmed their results, strengthened their 
hypothesis and helped to exclude factors such as skin texture, skin 
thickness, skin glycogen content and tissue water content that could 
influence the observed differences between mucosal and parakera totic 
skin. 
If their observations held true for the tail region, but there was no 
significant parakeratotic sloughing of DNA in the tail, one would 
assume that the DNA antigen is available at the D-E junction and the 
observed differences in mucosal and parakeratotic subepi-Ig deposit ion 
are due to some other cause. 
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REPLY 
We wish to thank Drs. Woodley and Prunieras for their thoughtful 
and constructive suggestion and reply simply that the tale of the tail 
has yet to be to ld. 
Richard D. Sontheimer, M.D. 
James N. Gilliam, M.D. 
CHRONIC TRICHOPHYTON RUBRUM INFECTION AND 
BLOODGROUPS 
T o the Editor: 
Drs. Young and Roth state in their article (Immunological Cross-
reactivity between a Glycoprotein Isolated from Trichophyton menta-
, grophytes and Human Isoant igen A, 72: 46-51,1979) that cross-reacting 
antigens from the mycelia l cell wall of T. menta.grophyles, T. rllbrllm 
and E. (toccoslim and human isoantigen A, may be a factor leading to 
chronic infection. They suggest that clinical studies on patients with 
chronic mycotic infections should include bloodgroup typing. 
In our series of 25 chronicaUy with T. rllbrum infected patients, 20 
belonged to the Royal Netherlands Navy personnel, so their blood-
groups could easily be traced. This group of patients was defined as 
follows. (1) A recorded duration of infection of more than 5 yr. (2) 
Immediate-type skin reactions to trichophytins in all patients, some 
which had concurrent delayed-type reactions. (3) Absence of so li tary 
de layed type skin reactions to trichophytins. (4) Normal skin response 
to other recall antigens. (5) Significantly more atopy and (6) signifi-
cantly more recurrences in a 2-3 year follow-up period, compared to 
noninfected pa tients and a group of patients with a acute T . rllbrllrrt 
infection (H. Neering and J . C. van der Horst, to be published) . 
The distribu t ion of the bloodgroups in these 20 patients was: A, 8 
(40%); B, 3 (15%); and 0 , 9 (45%). Rhesus-D pos were: 18 (90%) and 
Rhesus-D neg were 2 (10%). This distribution is essentially similar to 
the occurrence of bloodgroups and Rhesus factors in the Netherlands 
popula tion (A, 41 , 8%; B, 8.5%, AB, 3.0%; 0, 46.7%, Rhesus-D pos: 84% 
and Rhesus-D neg: 16%). 
We are, therefore, unable to add clinical evidence to the interesting 
findings ill the article mentioned above. 
Dr. H. Neering 
Dept. Dermato-Venereology 
Roya l Neth. Navy Hospita l 
Overveen 
Netherlands 
TYROSINE HYDROXYLATION 
To the Editor: 
In their article, Drs. Shapiro, Edelstein, Patel, Okun et al [1] pub-
lished some rather questionable conclusions based on data which might 
seem convincing to those not familiar with the field, and which I feel 
need some clru·ification. In their paper, they claimed their da ta sup-
ported the notion that mammalian tyrosinase (EC 1.14.18.1) was inca-
pable of tyrosine hydroxylation as determined by the tritiated water 
assay developed by Pomerantz [2]. There are a variety of papers in the 
literature, some of ours included, which have shown purified mamma-
lian tyrosinase to be capable of tyrosine hydroxyla tion, not only via the 
Pomerantz assay, but by several other types of methodologies as well 
[3-7]. Space does not allow a full critique of the paper-however, the 
inabili ty of the S hapiro group to confum th is may be due to one or 
more of the following considerations: 
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E lectrophoretic migration patterns of murine tyrosinases 
Authors Ref %1' Tissue T, T, 
B w-nett et al [10] 7.0 B-16 melanoma .61 .51 
Burnett et al [10] 7.0 Harding Passey melanoma .62 .52 
B urnett et al [10] 7.0 S-91 melanoma .62 .51 
Holstein et a l [11] 7.0 coat color mutants .69 .53 
Burnett et a l [1 2] 7.0 normal hair bulbs .70 .54 
Holstein et a l [13] 7.0 coat color mutants .70 .54 
Miyazaki & Seiji [14] 7.0 Harding Passey melanoma .63 
N ishioka et a l [7] 7.0 S-91 melanoma .65 .53 
.65 ± .04 .53 ± .01 
Hearing & Ekel [8] 7.5 S-91 melanoma .55 .44 
Eppig & Hearing [15] 7.5 normal epidermis .60 .46 
Eppig & Hearing [15] 7.5 S-91 melanoma .61 .46 
Klingler et a l [16] 7.5 B-16 melanoma .59 .50 
Klingler et a l [16] 7.5 S-91 melanoma .59 .50 
Wh ite & Hu [5] 7.5 B-16 melanoma .60 
H earing et al [6] 7.5 B-16 melanoma .56 .45 
.59 ± .02 .47 ± .03 
S h apiro et a l [1] 7.5 Harding-Passey melanoma .44 .30 
All figures are those given by the author (if none were given, actual gels were measured) . Most data represent the average of many such gels. 
1. The tyrosine level used in their assay (0.66 mM) has been shown 
to be inhib itory by several workers-the safest levels of tyrosine to use 
to avoid competitive inhibition is a full order of magnitude less 
[3, 8, 9]. 
2. More importantly, however, was the fac t that their enzyme prep-
aration most probably contained li ttle or no tyrosinase. In our earlier 
paper [8) which discussed the purification scheme employed by the 
Patel and Okun group, we showed tha t the technique modifications 
t h at they employed were less than adequate, since only about 0.2% of 
t h e tyrosinase activity was recovered, with a specific activity that was 
reduced, indicating no purification at all. S hapiro et al, employing those 
same methods for some reason, appear to have purified the same 
n o ntyrosinase proteins that we had shown by gel electrophoresis in our 
earLi er paper. A comparison of the impure preparations (cf their Fig 1, 
w ith more than 9 proteins) with the clean preparations of the original 
Burnett papers will suffice to prove this point. Further, a quick scan of 
t h e literature (Table 1) over the past 15 years on tyrosinases found in 
a variety of normal and malignant murine systems shows that the 
relative mobilit ies of the major isozyme (1',) on 7.5% acrylamide gels 
are around 0.59; on 7% ac rylamide gels, it moves even faster (R", 0.65). 
The 1'2 isozyme, which is a minor tyrosinase isozyme, is somewhat 
s lower . T he 2 bands purified by Shapiro et al had relative mobilities 
s ignificantly slower than that, 0.44 and 0.30, respectively. This is very 
close to the elec trophoretic da ta for DOPA-posit ive proteins that we 
obtained for the same preparation in our earlier paper (0.47 and 0.35) ; 
we have no idea what proteins these represent- they must be oxidizing 
in natw-e since we, as well as the Shapiro group, found that they were 
capable of oxidizing L· DOPA to melanin. It is feasib le that these bands 
represent hemoglobin, or a similar protein, which is capable of oxidizing 
L-DOPA; it should not be ignored that both Holstein et al [4] and 
White and Hu [5] demonstrated peroxidase in gels which migrated with 
a re lative mobility of around .38-thus these bands might represent 
peroxidase activity which was incapable of tyrosine hydroxylation. 
Lastly, it would have been in teresting if the S hapiro article had 
included data on analogous studies carried out on their peroxidase 
e nzyme(s), to enable one to see the electrophoretic characteristics of 
t his enzyme(s) and to assure us that its proposed tyrosine hydroxylation 
capabili ty could be determined with this same assay technique. 
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REPLY 
T he comments of Dr. Hearing are erroneous and misleading. Some 
of the points he has raised have been dealt with in previous published 
exchanges in the Journal of Investigative Dermatology. 
1. Dr. Hearing suggests that ow- inability to demonstrate hydroxyl-
ation of tyrosine by mammalian "tyrosinase" is related to the use of a 
concentration of tyrosine sufficient to produce total substrate inhibi-
tion. We are not aware of documentation of total substrate inhibition 
in any enzyme system. In a previous study [1] we used a range of 
tyrosine concentrations and found that this had no effect on the 
inabili ty of mammalian "tyrosinase" (dopa oxidase) to hydroxylate 
tyrosine. In addition, we repeated experiments in our current study, 
using a similar ra'nge of tyrosine concentration, without effect on our 
data. Conversely, hydroxyla tion of tyrosine by mushroom tyrosinase 
was easily demonstrable [2] using tyrosine concentrations equal to 
those employed wi th our mammalian "tyrosinase" experiments. 
2. Dr. Hearing's alleged inability to obtain adequate "tyrosinase" 
concent ration using our method is of no s ignificance and has no bearing 
on our results. His assay system was ambiguous, and his method of 
differentiating peroxidase from "tyrosinase" activity was withou t value 
for reasons cited previously [3]. In our previous experiments [2] and in 
the current study, our enzyme preparation (mammalian " tyrosinase" ) 
had good specific activi ty towards dopa, using non·ambiguous assay 
methods. 
3. Rx value of an enzyme will vary with many factors, including its 
polymeric form, binding to other proteins [4], and polymerization time 
used for the gel; pore size will vary with polymerization t ime. Therefore, 
Rx value cannot reliably be used as a parameter of enzyme identifica-
t ion. It is not clear why the dopa-positive bands he found at the Rx 
values cited in our current study did not represent "tyrosinase." We do 
not understand why Dr. Hearing could suggest that our dopa-positive 
bands represented hemoglobin or peroxidase, since we clearly stated 
that these bands were diaminobenzidine-negative, excluding these pos-
sibili ties. 
4. Dr. Hearing should be aware that electrophoretic characteristics 
of melanoma peroxidase cannot be determined, since this peroxidase is 
firmly membrane-bound. We made this point in our rebuttal to his 
previous paper [3]. 
The only way that the controversy about "~yrosinase" can be re-
solved is by step-by-step cross-verification of results, with exchange of 
starting materials and intermediates between laboratories with conflict-
ing data, as well as the use of non-ambiguous methods of enzyme assay. 
